CEROW
CERO THERAPEUTICS HOLDINGS, INC.
NASDAQ · Healthcare · Biotechnology · US
$0.00
+63.55%Price chart
Jun 4Jun 9Jul 7Jul 31Aug 17Sep 2Sep 18Oct 19
Key dataOct 19, 2026
Open$0.00
From 52W high−89.71%
Volume650.00
Market cap$4427.09
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataOct 19, 2026
Open
$0.00
From 52W high
−89.71%
Volume
650.00
Market cap
$4427.09
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.4x
P/E (TTM)
—
RSI (14)
52.5
MomentumView details →
1D Return
+63.55%
YTD Return
−26.79%
Similar companies
Latest newsMore news →
SRx Health Solutions, Inc. and its wholly owned SPV, CERO THERAPEUTICS HOLDINGS, INC., entered into a definitive agreement to acquire CERO THERAPEUTICS HOLDINGS, INC..12d agoSRX Global agreed to acquire all outstanding capital stock of CERO THERAPEUTICS HOLDINGS, INC. from CERO THERAPEUTICS HOLDINGS, INC. for $1 million in SRX common stock, forgiveness of an $8,249,643.77 promissory note and assumption of approximately $1.562 million in liabilities, subject to specified conditions.13d agoCERO Therapeutics Holdings, Inc. signed a consolidated senior secured promissory note with SRX Global Inc. for up to $11,666,108.77, consolidating previous notes and providing additional advances, with interest at 10% per annum and maturity on October 15, 2026.49d ago